Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Povzetek smernic za obravnavo bolnic z rakom jajčnikov, jajcevodov in s primarnim peritonealnim seroznim rakom
Authors:ID Zobec Logar, Helena Barbara (Author)
ID Smrkolj, Špela (Author)
ID Škof, Erik (Author)
ID Bebar, Sonja (Author)
Files:.pdf PDF - Presentation file, download (566,22 KB)
MD5: 587DF6B7D59A30B0B6008D97949C6894
PID: 20.500.12556/dirros/1b73775f-e460-4877-9a6e-fa05511f2df6
 
Language:Slovenian
Typology:1.04 - Professional Article
Organization:Logo OI - Institute of Oncology
Abstract:Smernice za obravnavo bolnic z rakom jajčnikov, jajcevodov in s primarnim peritonealnim seroznim rakom so izšle v samostojni obliki prvič po letu 2002. Tistega daljnega leta so bile smernice za vse ginekološke rake še združene v eni knji- žici, dandanes pa nova dejstva in spoznanja ter razvoj novih zdravil terjajo bolj poglobljen pristop k obravnavi teh bolnic. Avtorji smo še posebej veseli dejstva, da so prve samostojne smernice izšle ob 1. Ginekološki šoli z naslovom Rak jajčnikov, 13. novembra 2015, nekoliko dopolnjena 2. izdaja smernic pa je izšla ob ponovitvi šole 18. marca 2016. Namenoma smo iz teh smernic izpustili redke vrste raka jajčnikov (kot na primer germinalni in stromalni rak), saj sta klinična pot in potek bolezni pri teh oblikah drugačni. Smernice so na voljo v dveh knjižnih izdajah, v velikem formatu in žepni obliki, v spletni obliki pa so dostopne na spletni strani Onkološkega inštituta, kjer se bodo tudi sproti posodabljale. Slovenskih smernic nismo želeli le povzeti po vzoru tujih, temveč smo v njih vnesli tudi naše izkušnje z zdravljenjem teh bolezni.
Keywords:rak jajčnikov, rak jajcevodov, primarni peritonalni serozni rak, zdravljenje
Publication status:Published
Publication version:Version of Record
Year of publishing:2016
Number of pages:str. 27-39
Numbering:Letn. 20, št. 1
PID:20.500.12556/DiRROS-8150 New window
UDC:618.1
ISSN on article:1408-1741
COBISS.SI-ID:2413179 New window
Copyright:by Authors
Publication date in DiRROS:16.03.2018
Views:3532
Downloads:898
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija. strokovni časopis za zdravnike
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:03.01.2018

Secondary language

Language:English
Title:Summary Guidelines for Treating Ovarian Cancer and Primary Peritoneal Serous Carcinoma
Abstract:Guidelines for Treating Patients with Ovarian Cancer and Primary Peritoneal Serous Carcinoma were published separately for the first time after 2002. Back then guidelines for all gynecologic cancers were collected in one booklet, however new facts and discoveries as well as the development of new drugs require a more in-depth approach to treating these patients. Authors of this article are especially pleased that the first separate guidelines were published on 13 November 2015 accompanying the 1st School of Gynecology with the title Ovarian Cancer, and an updated version was published when the School of Gynecology was repeated on 18 March 2016. Rare types of ovarian cancer were left out of these guidelines on purpose (such as germ cell or stromal cancer), due to different treatment path and course of the disease. Guidelines are available in two printed versions – as a pocket book and in large format – and in electronic form on the website of the Institute of Oncology, where they will be regularly updated. We did not want the Slovenian guidelines to be based solely on similar foreign documents, and we added our experience with treating these diseases.


Archive

niGradiv

Back